Programs for control of congenital toxoplasmosis

Revista da Associacao Medica Brasileira

Volumn 57, Issue 5, 2011, Pages 581-586

  Lopes Mori, Fabiana Maria Ruiz ^a   Mitsuka Breganó, Regina ^a   Capobiango, Jaqueline Dario ^a   Inoue, Inácio Teruo ^a   Reiche, Edna Maria Vissoci ^a   Morimoto, Helena Kaminami ^a   Casella, Antônio Marcelo Barbante ^a   Bittencourt, Laura França de Barros ^a   Freire, Roberta Lemos ^a   Navarro, Italmar Teodorico ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Congenital; Health programs and plans; Pregnant women; Primary prevention; Secondary prevention; Tertiary prevention; Toxoplasmosis

Indexed keywords

EID: 80054724903     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0104-4230(11)70117-8     Document Type: Article

References (42)

1. Sparkes AH. Toxoplasmosis en el gato y en el hombre. In: Anais do Congresso de la Asociación Mundial de Medicina Veterinaria de Pequeños Animales. Associación Mundial de Medicina Veterinária de Pequeños Animales; 1998. pp. 415-17.
2. Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'amico R et al. Prenatal education for congenital toxoplasmosis (Review). The Cochrane Collaboration; 2009. Issue 1.
3. Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammala P et al. Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis 1995;27:265-72.
4. Logar J, Petrovec M, Novak-Antolic Z, Premru-Srsen T, Cizman M, Arnez M et al. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant woman. Scand J Infect Dis 2002;34:201-4.
5. Lago EG, Neto EC, Melamed J, Rucks AP, Presotto C, Coelho JC et al. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatr Perinat Epidemiol 2007;21:525-31.
6. Jones JI, Kruszon-Moran D, Wilson M, Mcquillan G, Navin T, Mcauley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001;154:357-65.
7. Jones JI, Lopez A, Wilson M. Congenital Toxoplasmosis. Am Fam Phys 2003;67:2131-8.
8. Pawlowski ZS, Gromadecka-Sutkiewicz M, Skommer J, Paul M, Rokossowski H, Suchocka E et al. Impact of health education on knowledge and prevention behavior for congenital toxoplasmosis: the experience in Poznan, Poland. Health Educ Res 2001;16:493-02.
9. Foulon W, Naessens A, Lawers S, De Meuter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol 1988;72:363-6.
10. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol 1994;11:57-62.
11. Buffolano W. Congenital toxoplasmosis: the state of the art. Parasitologia 2008;50:37-43.
12. Thulliez P. Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis 1992;84(Suppl):43-5.
13. Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992;84(Suppl):32-77.
14. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Petersen B et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 1999;353:1834-37.
15. Paul M, Petersen E, Pawlowski ZS, Szczapa J. Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 2000;19:30-6.
16. Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington J et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol 2005;192:564-71.
17. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen 2002;9:135-41.
18. Castilho-Pelloso MP, Falavigna DLM, Araújo SM, Falavigna-Guilherme AL. Monitoramento de gestantes com toxoplasmose em serviços públicos de saúde. Rev Soc Bras Med Trop 2005;38:532-3.
19. Margonato FB, Silva AMR, Soares DA, Amaral DA, Petris AJ. Toxoplasmose na gestação: diagnóstico, tratamento e importância de protocolo clínico. Rev Bras Saude Mater Infant 2007;7:381-6.
20. Mitsuka-Breganó R. Programa de Vigilância em Saúde da Toxoplasmose Gestacional e Congênita: elaboração, implantação e avaliação no município de Londrina, Paraná [thesis]. Londrina: Universidade Estadual de Londrina; 2009.
21. Gilbert R, Gras L. European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Int J Obstet Gynaecol 2003;110:112-20.
22. Eskild A, Magnus P. Little evidence of effective prenatal treatment against congenital toxoplasmosis-the implications for testing in pregnancy. Int J Epidemiol 2001;30:1314-5.
23. Villena I, Ancelle T, Delmas C, Garcia P, Brézin AP, Thulliez P et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Surveill Outbreak Rep 2010;15:1-6.
24. Edelhofer R, Prossinger H. Infection with Toxoplasma gondii during pregnancy: seroepidemiological studies in Austria. Zoonoses Public Health 2010;57:18-26.
25. Carellos EVM, Andrade GMG, Aguiar RALP. Evaluation of prenatal screening for toxoplasmosis in Belo Horizonte, Minas Gerais State, Brazil: a cross-sectional study of postpartum women in two maternity hospitals. Cad Saúde Pública 2008;24:391-401.
26. Khoshnood B, De Vigan C, Goffinet F, Leroy V. Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening. Prenat Diagn 2007;27:395-403.
27. Remington JS, Mcleod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: Elsevier Saunders; 2006. pp. 947-1091.
28. Kravetz JD, Federman DG. Toxoplasmosis in pregnancy. Am J Med 2005;118:212-8.
29. NSC-National Screening Committee Working Group Antenatal and Newborn Screening for Toxoplasmosis. Report of the Working Group. National Screening Committee; 2001.
30. Gilbert R, Dunn D, Wallon M, Hayde M, Prusa A, Lebech M et al. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol. Epidemiol Infect 2001;33:113-210.
31. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66:767-74.
32. Montoya J, Rosso F. Diagnosis and management of toxoplasmosis. Clin Perinat 2005;32:705-26.
33. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B et al. Neonatal serologic screening and early treatment for congenital toxoplasmosis Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994;330:1858-63.
34. Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E, European Multicentre Study on Congenital Toxoplasmosis. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 2007;14:8-13.
35. Curitiba. Secretaria Municipal de Saúde. Programa Mãe Curitibana. Curitiba; 2004.
36. Figueiro-Filho EA, Senefonte FR, Lopes AHA, Morais OO, Souza Júnior VG, Maia TL et al. Frequency of HIV-1, rubella, syphilis, toxoplasmosis, cytomegalovirus, simple herpes virus, hepatitis B, hepatitis C, Chagas disease and HTLV I/II infection in pregnant women of State of Mato Grosso do Sul. Rev Soc Bras Med Trop 2007;40:181-7.
37. Giffoni AA. Toxoplasmose em gestantes: abordagem epidemiológica nos postos de saúde da rede pública da cidade de Rio Verde, Goiás [dissertation]. Brasília (DF): Universidade de Brasília; 2007.
38. Batista KBC, Lago TDG, Lavras CCC. Atenção à gestante e à puérpera no SUS-SP: manual técnico do pré-natal e puerpério. São Paulo: Secretaria da Saúde; 2010. pp. 1-234.
39. Neto EC, Rubin R, Schulte J, Giugliani R. Newborn screening for congenital infectious diseases. Emerg Infect Dis 2004;10:1068-73.
40. Vasconcelos-Santos DV, Azevedo DOM, Campos WR, Oréfice F, Queiroz-Andrade GM, Carellos EVM et al. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 2009;116:2199-205.
41. Mitsuka-Breganó R, Lopes-Mori FMR, Navarro IT. Toxoplasmose adquirida na gestação e congênita: vigilância em saúde, diagnóstico, tratamento e condutas. Londrina: EDUEL; 2010. pp.1-62.
42. Lopes FMR, Mitsuka-Breganó R, Gonçalves DD, Freire RL, Karigyo CJT, Wedy GF et al. Factors associated with seropositivity for anti-Toxoplasma gondii antibodies in pregnant women of Londrina, Paraná, Brazil. Mem Inst Oswaldo Cruz 2009;104:378-82.